Evidence map›Paper›PMID 39440485›Full record

ArticleFuture medicinal chemistry2024

Synthesis of new 1,4-dihydropyridine derivative, anti-cancer, bacterial activity, molecular docking and adsorption, distribution, metabolism and excretion analysis.

Radadhakrishnan Surendrakumar, Akbar Idhayadhulla, Thilagavathi Govindasamy, Natarajan Elangovan, Eman Aldosari, Mohammad Shahidul Islam

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Future medicinal chemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Radadhakrishnan SurendrakumarDepartment of Chemistry, Nehru Memorial College (Affiliated to Bharathidasan University), Puthanampatti, Tamil Nadu, India.
Akbar IdhayadhullaDepartment of Chemistry, Nehru Memorial College (Affiliated to Bharathidasan University), Puthanampatti, Tamil Nadu, India.
Thilagavathi GovindasamyDepartment of Physics, Nehru Memorial College (Affiliated to Bharathidasan University), Puthanampatti, Tamil Nadu, India.
Natarajan ElangovanCentre for Global Health Research, Saveetha Medical College, Saveetha Institute of Medical and Technical Sciences, India.ORCID 0000-0002-8665-0519
Eman AldosariDepartment of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
Mohammad Shahidul IslamDepartment of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.ORCID 0000-0002-4612-5875

Funding

King Saud University RSPD2024R845Nehru Memorial College, Puthanampatti, Trichy, Tamil Nadu, India SR/FST/COLLEGE-372/2018
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsAntineoplastic AgentsDihydropyridinesMolecular Docking SimulationAdsorptionCell ProliferationDrug Screening Assays, AntitumorEscherichia coliHumansMCF-7 CellsMicrobial Sensitivity TestsMolecular StructureStructure-Activity Relationship1,4-dihydropyridineAnti-Bacterial AgentsAntineoplastic AgentsDihydropyridines1,4-dihydropyridineADMEanti-bacterial activitycytotoxicitystructure–activity relationshipthiadiazoletriazole

Identifiers

PMID39440485
PMCPMC11622802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.